The Lurie Center for Autism invites you to join Ann Neumeyer, MD and Chris Keary, MD for a presentation on the clinical use of leucovorin and mirtazapine. Leucovorin (folinic acid) has been suggested as a treatment for autism. The session will highlight what we have learned from clinical research studies in children with autism and its use in treating children with cerebral folate deficiency. The presenters will also review results from the Lurie Center for Autism's clinical trial of the anti-anxiety medication mirtazapine, including its implications for patients with autism and anxiety.

Coffee Convo presentations are offered monthly. All events are conducted virtually, free of charge, and open to the general public. Follow the link below to confirm your registration for the December event. The event meeting link will be sent to registered participants the day before each event.